HCA Healthcare (NYSE:HCA) Price Target Raised to $475.00

HCA Healthcare (NYSE:HCA) had its target price lifted by KeyCorp from $465.00 to $475.00 in a research note published on Monday morning,Benzinga reports. KeyCorp currently has an overweight rating on the stock.

Several other equities analysts also recently weighed in on HCA. Robert W. Baird boosted their target price on HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research report on Thursday, August 14th. Morgan Stanley cut their target price on HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating on the stock in a research report on Monday, July 28th. UBS Group boosted their target price on HCA Healthcare from $438.00 to $495.00 and gave the company a “buy” rating in a research report on Tuesday, October 14th. Wolfe Research downgraded HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research report on Monday, July 28th. Finally, Bank of America boosted their target price on HCA Healthcare from $375.00 to $410.00 and gave the company a “neutral” rating in a research report on Wednesday, September 10th. Fourteen equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $473.53.

HCA Healthcare Stock Up 0.4%

Shares of HCA Healthcare stock opened at $468.21 on Monday. The firm has a market cap of $109.56 billion, a price-to-earnings ratio of 18.10, a PEG ratio of 1.37 and a beta of 1.40. The business has a 50-day moving average price of $418.76 and a 200-day moving average price of $385.09. HCA Healthcare has a twelve month low of $289.98 and a twelve month high of $475.38.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping the consensus estimate of $5.64 by $1.32. The company had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm’s revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the business posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities analysts expect that HCA Healthcare will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is 11.13%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

Institutional Investors Weigh In On HCA Healthcare

Hedge funds have recently made changes to their positions in the company. Cheviot Value Management LLC purchased a new stake in shares of HCA Healthcare in the 1st quarter worth $26,000. Saudi Central Bank purchased a new stake in shares of HCA Healthcare in the 1st quarter worth $26,000. WPG Advisers LLC purchased a new stake in shares of HCA Healthcare during the 1st quarter worth $27,000. Ameriflex Group Inc. purchased a new stake in shares of HCA Healthcare during the 2nd quarter worth $27,000. Finally, Chung Wu Investment Group LLC purchased a new stake in shares of HCA Healthcare during the 2nd quarter worth $27,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.